Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 5.11% is 736% above its 5-year average of 0.61%, around the middle of its 5-year range (-13.41%–14.62%).
As of the fiscal period ended Tuesday, June 30, 2026. 261.42% above its 12-month average of 1.41%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 5.11%.
RETURN ON INVESTED CAPITAL (ROIC)
5.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
1.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-1.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
0.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
1.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+261.42%
CURRENT VS 3Y AVG
+516.77%
CURRENT VS 5Y AVG
+735.95%
CURRENT VS 10Y AVG
+290.66%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 725 covered companies
CURRENT VS SECTOR MEDIAN
+115.24%
vs the sector median at left
The Joint Corp.
Market Cap
$103.07M
Return on Invested Capital (ROIC)
5.11%
TTM Avg
1.41%
3Y Avg
-1.23%
5Y Avg
0.61%
Market Cap
$103.09M
Return on Invested Capital (ROIC)
-82.35%
TTM Avg
-77.56%
3Y Avg
-62.72%
5Y Avg
-68.20%
Market Cap
$102.56M
Return on Invested Capital (ROIC)
-35.98%
TTM Avg
-82.06%
3Y Avg
-144.65%
5Y Avg
-107.36%
Market Cap
$105.01M
Return on Invested Capital (ROIC)
41.64%
TTM Avg
-39.48%
3Y Avg
-25.23%
5Y Avg
-17.21%
Market Cap
$105.67M
Return on Invested Capital (ROIC)
-47.75%
TTM Avg
-127.40%
3Y Avg
-174.63%
5Y Avg
-174.63%
Market Cap
$99.27M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$107.28M
Return on Invested Capital (ROIC)
-101.30%
TTM Avg
-45.83%
3Y Avg
-127.78%
5Y Avg
-123.84%
Market Cap
$107.43M
Return on Invested Capital (ROIC)
-34.77%
TTM Avg
-10.04%
3Y Avg
-11.68%
5Y Avg
-11.21%
Market Cap
$98.56M
Return on Invested Capital (ROIC)
13.49%
TTM Avg
-178.47%
3Y Avg
-181.87%
5Y Avg
-147.13%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Joint Corp. (JYNT) | $103.07M | 5.11% | 1.41% | -1.23% | 0.61% |
| Anixa Biosciences, Inc. (ANIX)vs › | $103.09M | -82.35% | -77.56% | -62.72% | -68.20% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $102.56M | -35.98% | -82.06% | -144.65% | -107.36% |
| Definitive Healthcare Corp. (DH)vs › | $105.01M | 41.64% | -39.48% | -25.23% | -17.21% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $105.67M | -47.75% | -127.40% | -174.63% | -174.63% |
| Conexeu Sciences Inc. (CNXU)vs › | $99.27M | N/A | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.28M | -101.30% | -45.83% | -127.78% | -123.84% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.43M | -34.77% | -10.04% | -11.68% | -11.21% |
| PolyPid Ltd. (PYPD)vs › | $98.56M | 13.49% | -178.47% | -181.87% | -147.13% |
| Immunic, Inc. (IMUX)vs › | $108.15M | -92.16% | -430.04% | -259.02% | -188.28% |
ROIC
5.1%
ROE
24.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 5.11% |
| 2026-03-31 | 2.31% |
| 2025-12-31 | -3.24% |
| 2025-09-30 | 5.98% |
| 2025-06-30 | -3.09% |
| 2025-03-31 | -5.23% |
| 2024-12-31 | -4.55% |
| 2024-09-30 | -13.41% |
| 2024-06-30 | -6.71% |
| 2024-03-31 | -3.53% |
| 2023-12-31 | -2.13% |
| 2023-09-30 | -0.56% |
| 2023-06-30 | 0.95% |
| 2023-03-31 | 0.03% |
| 2022-12-31 | 0.74% |
| 2022-09-30 | -0.94% |
| 2022-06-30 | -0.04% |
| 2022-03-31 | 5.19% |
| 2021-12-31 | 8.16% |
| 2021-09-30 | 13.20% |
| 2021-06-30 | 14.62% |
| 2021-03-31 | 13.09% |
| 2020-12-31 | 10.95% |
| 2020-09-30 | 10.31% |
| 2020-06-30 | 8.06% |
| 2020-03-31 | 9.62% |
| 2019-12-31 | 11.51% |
| 2019-09-30 | 10.28% |
| 2019-06-30 | 8.79% |
| 2019-03-31 | 6.93% |
| 2018-12-31 | 1.29% |
| 2018-09-30 | -6.97% |
| 2018-06-30 | -8.58% |
| 2018-03-31 | -15.99% |
| 2017-12-31 | -26.36% |
| 2017-09-30 | -74.59% |
| 2017-06-30 | -93.83% |
| 2017-03-31 | -112.55% |
| 2016-12-31 | -130.38% |
| 2016-09-30 | -74.78% |
| 2016-06-30 | -59.88% |
| 2016-03-31 | -47.41% |
| 2015-12-31 | -35.39% |
| 2015-09-30 | -39.54% |
| 2015-06-30 | -26.09% |
| 2015-03-31 | -15.41% |
| 2014-12-31 | -6.64% |
| 2014-09-30 | -9.26% |
| 2014-06-30 | -0.53% |
